ARTTX
Price
$25.74
Change
+$0.08 (+0.31%)
Updated
Aug 6 closing price
Net Assets
1.22B
GFACX
Price
$71.52
Change
+$0.63 (+0.89%)
Updated
Aug 6 closing price
Net Assets
324.74B
Interact to see
Advertisement

ARTTX vs GFACX

Header iconARTTX vs GFACX Comparison
Open Charts ARTTX vs GFACXBanner chart's image
Artisan Focus Fund Investor
Price$25.74
Change+$0.08 (+0.31%)
VolumeN/A
Net Assets1.22B
American Funds Growth Fund of Amer C
Price$71.52
Change+$0.63 (+0.89%)
VolumeN/A
Net Assets324.74B
ARTTX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARTTX vs. GFACX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTTX is a StrongBuy and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 325B vs. ARTTX (1.22B). ARTTX (0.00) and GFACX (0.00) have matching dividends . ARTTX was incepted earlier than GFACX: ARTTX (8 years) vs GFACX (24 years). GFACX (1.36) and ARTTX (1.30) have similar cost to investors . ARTTX is a more actively managed with annual turnover of: 401.50 vs. GFACX (25.00). GFACX has a lower initial minimum investment than ARTTX: GFACX (250) vs ARTTX (1000). ARTTX annual gain was more profitable for investors over the last year : 21.19 vs. GFACX (18.41). ARTTX return over 5 years is better than : 41.51 vs. GFACX (33.13).
ARTTXGFACXARTTX / GFACX
Total Expense Ratio1.301.3696%
Annual Report Gross Expense Ratio1.301.3696%
Fund Existence8 years24 years-
Gain YTD19.83212.171163%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.22B325B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.1918.41115%
Returns for 3 years47.6839.63120%
Returns for 5 years41.5133.13125%
Returns for 10 yearsN/A67.85-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.260.14
+6.60%
Spero Therapeutics
UXIN3.830.11
+2.96%
Uxin Limited
CCRN13.100.26
+2.02%
Cross Country Healthcare
GBDC14.78-0.01
-0.07%
Golub Capital BDC
CRBG34.23-0.07
-0.20%
Corebridge Financial